Skip to content
10-Q

Quarterly Report

Seelos Therapeutics, Inc.

0001410578-24-001435

← back to feed
Filed
Aug 14, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 6, 2024 5.96M sh
Shares Diluted Q2 2024 · Jun 30, 2024 2.52M sh
Shares Diluted Q2 2024 · Jun 30, 2024 2.07M sh
Shares Diluted restated Q2 2024 · Jun 30, 2023 549.7K sh
Shares Diluted restated Q2 2024 · Jun 30, 2023 509.56K sh
Operating Cash Flow Q2 2024 · Jun 30, 2024 −$5.61M
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$16.25M
Long Term Debt Q2 2024 · Jun 30, 2024 $10.1M
Stockholders Equity Q2 2024 · Jun 30, 2024 −$28.13M
Stockholders Equity Q2 2024 · Mar 31, 2024 −$33.1M
Stockholders Equity Q2 2024 · Dec 31, 2023 −$33.51M
Stockholders Equity Q2 2024 · Jun 30, 2023 −$47.18M
Stockholders Equity Q2 2024 · Mar 31, 2023 −$20.66M
Stockholders Equity Q2 2024 · Dec 31, 2022 −$10.61M
Current Liabilities Q2 2024 · Jun 30, 2024 $30.51M
Current Liabilities Q2 2024 · Dec 31, 2023 $38.93M
Total Liabilities Q2 2024 · Jun 30, 2024 $30.51M
Total Liabilities Q2 2024 · Dec 31, 2023 $38.93M
Current Assets Q2 2024 · Jun 30, 2024 $2.33M
Current Assets Q2 2024 · Dec 31, 2023 $5.4M
Total Assets Q2 2024 · Jun 30, 2024 $2.38M
Total Assets Q2 2024 · Dec 31, 2023 $5.42M
Eps Diluted Q2 2024 · Jun 30, 2024 $0.12
Eps Diluted Q2 2024 · Jun 30, 2024 −$0.46
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$53.66
Eps Diluted restated Q2 2024 · Jun 30, 2023 −$84.24
Eps Basic Q2 2024 · Jun 30, 2024 $0.68
Eps Basic Q2 2024 · Jun 30, 2024 −$0.46
Eps Basic restated Q2 2024 · Jun 30, 2023 −$53.66
Eps Basic restated Q2 2024 · Jun 30, 2023 −$84.24
Rd Expense Q2 2024 · Jun 30, 2024 $966K
Rd Expense Q2 2024 · Jun 30, 2024 $4.49M
Rd Expense Q2 2024 · Jun 30, 2023 $8.51M
Rd Expense Q2 2024 · Jun 30, 2023 $14.18M
Net Income Q2 2024 · Jun 30, 2024 $1.71M
Net Income Q2 2024 · Jun 30, 2024 −$954K
Net Income Q2 2024 · Jun 30, 2023 −$29.5M
Net Income Q2 2024 · Jun 30, 2023 −$42.93M
Operating Income Q2 2024 · Jun 30, 2024 −$3.14M
Operating Income Q2 2024 · Jun 30, 2024 −$9.19M
Operating Income Q2 2024 · Jun 30, 2023 −$10.95M
Operating Income Q2 2024 · Jun 30, 2023 −$19.89M
Revenue Q2 2024 · Jun 30, 2024 $376K
Revenue Q2 2024 · Jun 30, 2024 $955K
Revenue Q2 2024 · Jun 30, 2023 $336K
Revenue Q2 2024 · Jun 30, 2023 $1.14M
Stock Repurchased Q2 2024 · Jun 30, 2023 $1.2M